Osaic Holdings’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38K Buy
1,190
+639
+116% +$21.1K ﹤0.01% 5671
2026
Q1
$21.1K Sell
551
-637
-54% -$20.6K ﹤0.01% 5822
2025
Q4
$31.2K Sell
1,188
-4
-0.3% -$73 ﹤0.01% 5562
2025
Q3
$16.1K Buy
1,192
+183
+18% +$2.09K ﹤0.01% 6076
2025
Q2
$9.65K Buy
1,009
+174
+21% +$1.65K ﹤0.01% 6174
2025
Q1
$7.76K Buy
835
+813
+3,695% +$10.5K ﹤0.01% 5922
2024
Q4
$306 Sell
22
-183
-89% -$3.32K ﹤0.01% 7118
2024
Q3
$4.82K Buy
205
+171
+503% +$3.59K ﹤0.01% 6214
2024
Q2
$544 Buy
+34
New +$585 ﹤0.01% 6963
2022
Q3
Sell
-1
Closed 7514
2022
Q2
$0 Buy
+1
New +$8 ﹤0.01% 7603

Other funds holding TYRA

Osaic Holdings's TYRA Position: Q2 2026 in Review

Osaic Holdings increased its Tyra Biosciences (TYRA) stake by 116% in Q2 2026, buying an estimated $21.1K and bringing the position to 1,190 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #5671.

Osaic Holdings first reported a position in TYRA in Q2 2022 and has held it in 10 quarters since. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Osaic Holdings held 1,190 shares of Tyra Biosciences worth $38K as of Q2 2026.
  • Osaic Holdings bought 639 Tyra Biosciences shares in Q2 2026, an estimated $21.1K.
  • Tyra Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5671 holding.
  • Osaic Holdings first reported a position in Tyra Biosciences in Q2 2022 and has held it in 10 quarters since.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.